Ionova Life Science Announces New Financing Round Of Usd $100 Million

On August 27, 2021, Shenzhen IONOVA Life Science Co., Ltd. ("IONOVA" or "the company"), a clinical-stage biotechnology company located in the Guangdong-Hong Kong-Macao Greater Bay Area of China, announced completion of a new financing round of USD $100 million, jointly led by Tsing Song Capital, Shenzhen Capital Group Company, Ltd. ("SCGC"), and Greater Bay Area Homeland Development Fund, with existing shareholders Dyee Capital and Lilly Asia Ventures (LAV) adding to their holdings. Life Venture served as financial advisor.